Press Releases :: Journey Medical Corporation (DERM)

May 4, 2023

Journey Medical Corporation to Announce First Quarter 2023 Financial Results on May 11, 2023

Mar 29, 2023

Journey Medical Corporation Reports Full-Year 2022 Financial Results and Recent Corporate Highlights

Mar 22, 2023

Journey Medical Corporation to Announce Year End 2022 Financial Results on March 29, 2023

Mar 16, 2023

Journey Medical Corporation Announces Completion of Treatment Assessing Impact of DFD-29 (Minocycline Modified Release Capsules 40 mg) on Microbial Flora in a Separate Phase 1 Clinical Trial

Mar 7, 2023

Journey Medical Corporation to Participate in the 35th Annual ROTH Conference

Jan 20, 2023

Journey Medical Corporation Appoints Joseph Benesch as Interim Chief Financial Officer

Jan 10, 2023

Journey Medical Corporation Completes Enrollment in Phase 3 Clinical Trials Evaluating DFD-29 (Minocycline Modified Release Capsules 40 mg) for the Treatment of Papulopustular Rosacea

Dec 20, 2022

Journey Medical Corporation Announces Positive Comparative Pharmacokinetic (PK) Data for DFD-29

Dec 5, 2022

Journey Medical Corporation to Participate in Cantor Medical & Aesthetic Dermatology, Ophthalmology & MedTech/Diagnostic Conference

Nov 10, 2022

Journey Medical Corporation Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights

rss_feed News RSS